Table 2.
CAD presentations and treatment.
| Characteristic | n (%) |
|---|---|
| CAD | 34 (41) |
| STEMI | 11 (all underwent PPCI) |
| NSTEMI | 13 |
| SA | 11 |
| Asymptomatic CAD | 6 |
| Current mean age, years | 51.7 (SD 7.6) |
| Mean age at HIV diagnosis, years | 37.3 (SD 9.6) |
| Mean age at CAD diagnosis, years | 48.3 (SD 7.5) |
| Mean duration of antiretroviral therapy, months | 105.7 (SD 69.7) |
| Risk factor profile | |
| Smoker | 25 (61.0) |
| Hypertension | 21(50.0) |
| Diabetes | 12 (29.0) |
| Dyslipidaemia | 33 (80.0) |
| Family history | 15 (36.0) |
| CKD | 3 (8.8) |
| Hepatitis B/C infection | 8 (23.5) |
| Illicit drug use, including cocaine | 7 (20.5) |
| Drug history at the time of diagnosis of CAD | |
| Antiretroviral drugs | 32 (94) |
| Antihypertensive drugs | 19 (56) |
| Antidiabetic drugs | 12 (35) |
| Lipid lowering drugs | 21 (62) |
| Frequently used antiretroviral drug groups | |
| NRTI alone | 4 (12) |
| NRTI + PI | 14 (41) |
| NRTI + NNRTI | 4 (12) |
| PI + raltegravir | 4 (12) |
| Treatments | |
| PCI | 27 (66) |
| OMT | 12 (31) |
| CABG | 2 (3) |
CABG = coronary artery bypass grafting; CAD = coronary artery disease; CKD = chronic kidney disease; NNRTI = non-nucleoside reverse transcriptase inhibitors; NRTI = nucleoside reverse transcriptase inhibitors; NSTEMI = non-ST segment elevation myocardial infarction; OMT = optimal medical therapy; PPCI = primary percutaneous coronary intervention; PI = protease inhibitors; SA = stable angina; SD = standard deviation; STEMI = ST segment elevation myocardial infarction.